Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2024 Filed Feb 16, 2024 16:20 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007016 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 174,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. F2 · ownership.nature: Common stock beneficially owned by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 16:20 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007016 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:20 UTC |
Branitzky OronDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007018 · ownership.xml · nonDerivative · entry 1 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Restricted stock units granted under the My Size, Inc. 2017 Equity Incentive Plan, which vest on January 1, 2025. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:20 UTC |
Kaufman ArikDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007020 · ownership.xml · nonDerivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Restricted stock units granted under the My Size, Inc. 2017 Equity Incentive Plan, which vest on January 1, 2025. Read SEC document |
| November 29, 2023 Filed Dec 4, 2023 16:15 UTC |
Luzon RonenDirector · Chief Executive Officer
|
SaleCommon Stock | 4,683 | $0.68 | $3,202.24 |
DisclosureSEC source: 0001493152-23-043558 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · shares: The reported sale of 4,683 shares of the issuer's common stock occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023. F1 · ownership.direct: The reported sale of 4,683 shares of the issuer's common stock occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023. Read SEC document |
| September 06, 2023 Filed Sep 13, 2023 20:15 UTC |
Turchinsky IliaFormer CTO
|
SaleCommon Stock | 1,211 | $1.41 | $1,707.51 |
DisclosureSEC source: 0001493152-23-032483 · ownership.xml · nonDerivative · entry 1 Turchinsky Ilia · CIK 0001774527 · Former CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,776 F1 · balance_after: In recognition of his service to the issuer, the Reporting Person's non-vested restricted stock awards were accelerated effective July 31, 2023, immediately prior to the effectiveness of his departure from the Company. Read SEC document |
| August 24, 2023 Filed Aug 31, 2023 20:15 UTC |
Turchinsky IliaFormer CTO
|
SaleCommon Stock | 2,013 | $2.47 | $4,972.11 |
DisclosureSEC source: 0001493152-23-031054 · ownership.xml · nonDerivative · entry 1 Turchinsky Ilia · CIK 0001774527 · Former CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,987 F1 · balance_after: In recognition of his service to the issuer, the Reporting Person's non-vested restricted stock awards were accelerated effective July 31, 2023, immediately prior to the effectiveness of his departure from the Company. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Elmaliah OrenDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 40 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024750 · ownership.xml · derivative · entry 4 Elmaliah Oren · CIK 0001713701 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40 Underlying: Common Stock, $.001 par value per share · 40 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Elmaliah OrenDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 40 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024750 · ownership.xml · derivative · entry 3 Elmaliah Oren · CIK 0001713701 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 40 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Elmaliah OrenDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 1,200 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024750 · ownership.xml · derivative · entry 2 Elmaliah Oren · CIK 0001713701 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock, $.001 par value per share · 1,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Elmaliah OrenDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,200 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024750 · ownership.xml · derivative · entry 1 Elmaliah Oren · CIK 0001713701 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Pardo BillyCPO & COO
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 1,601 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024751 · ownership.xml · derivative · entry 8 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,601 Underlying: Common Stock, $.001 par value per share · 1,601 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer and Director Ronen Luzon). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Pardo BillyCPO & COO
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,601 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024751 · ownership.xml · derivative · entry 7 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,601 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer and Director Ronen Luzon). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Pardo BillyCPO & COO
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 6,400 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024751 · ownership.xml · derivative · entry 6 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,400 Underlying: Common Stock, $.001 par value per share · 6,400 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer and Director Ronen Luzon). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Pardo BillyCPO & COO
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 6,400 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024751 · ownership.xml · derivative · entry 5 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 6,400 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer and Director Ronen Luzon). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Pardo BillyCPO & COO
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 894 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024751 · ownership.xml · derivative · entry 4 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 894 Underlying: Common Stock, $.001 par value per share · 894 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Pardo BillyCPO & COO
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 894 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024751 · ownership.xml · derivative · entry 3 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 894 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Pardo BillyCPO & COO
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 5,200 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024751 · ownership.xml · derivative · entry 2 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,200 Underlying: Common Stock, $.001 par value per share · 5,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Pardo BillyCPO & COO
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 5,200 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024751 · ownership.xml · derivative · entry 1 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 5,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:04 UTC |
Kles OrChief Financial Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 5,200 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024749 · ownership.xml · derivative · entry 4 Kles Or · CIK 0001686316 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,200 Underlying: Common Stock, $.001 par value per share · 5,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:04 UTC |
Kles OrChief Financial Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 5,200 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024749 · ownership.xml · derivative · entry 3 Kles Or · CIK 0001686316 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 5,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:04 UTC |
Kles OrChief Financial Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 560 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024749 · ownership.xml · derivative · entry 2 Kles Or · CIK 0001686316 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 560 Underlying: Common Stock, $.001 par value per share · 560 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:04 UTC |
Kles OrChief Financial Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 560 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024749 · ownership.xml · derivative · entry 1 Kles Or · CIK 0001686316 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 560 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 894 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 8 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 894 Underlying: Common Stock, $.001 par value per share · 894 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 894 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 7 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 894 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 5,200 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 6 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,200 Underlying: Common Stock, $.001 par value per share · 5,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 5,200 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 5 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 5,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 1,601 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 4 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,601 Underlying: Common Stock, $.001 par value per share · 1,601 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,601 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 3 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,601 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 6,400 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,400 Underlying: Common Stock, $.001 par value per share · 6,400 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 6,400 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 6,400 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:02 UTC |
Kaufman ArikDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 40 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024748 · ownership.xml · derivative · entry 4 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40 Underlying: Common Stock, $.001 par value per share · 40 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:02 UTC |
Kaufman ArikDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 40 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024748 · ownership.xml · derivative · entry 3 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 40 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:02 UTC |
Kaufman ArikDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 1,200 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024748 · ownership.xml · derivative · entry 2 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock, $.001 par value per share · 1,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:02 UTC |
Kaufman ArikDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,200 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024748 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:01 UTC |
Branitzky OronDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 40 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024747 · ownership.xml · derivative · entry 4 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40 Underlying: Common Stock, $.001 par value per share · 40 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:01 UTC |
Branitzky OronDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 40 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024747 · ownership.xml · derivative · entry 3 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 40 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:01 UTC |
Branitzky OronDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 1,200 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024747 · ownership.xml · derivative · entry 2 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock, $.001 par value per share · 1,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:01 UTC |
Branitzky OronDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,200 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024747 · ownership.xml · derivative · entry 1 Braniztky Oron · CIK 0001714993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 16:30 UTC |
Pardo BillyChief Operating Officer
|
GrantCommon Stock | 2,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027436 · ownership.xml · nonDerivative · entry 2 Pardo Billy · CIK 0001686858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,617,064 F2 · ownership.nature: Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 16:30 UTC |
Pardo BillyChief Operating Officer
|
GrantCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027436 · ownership.xml · nonDerivative · entry 1 Pardo Billy · CIK 0001686858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2023, January 1, 2024 and January 1, 2025, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 16:33 UTC |
Kles OrChief Financial Officer
|
GrantCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027443 · ownership.xml · nonDerivative · entry 1 Kles Or · CIK 0001686316 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2023, January 1, 2024 and January 1, 2025, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 16:30 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027433 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 600,000 F2 · ownership.nature: Common stock beneficially owned by Spouse (Chief Operating Officer Billy Pardo) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 16:30 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantCommon Stock | 2,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027433 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,617,064 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2023, January 1, 2024 and January 1, 2025, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 20:33 UTC |
Turchinsky IliaChief Technology Officer
|
GrantCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027444 · ownership.xml · nonDerivative · entry 1 Turchinsky Ilia · CIK 0001774527 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2023, January 1, 2024 and January 1, 2025, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 20:30 UTC |
Brandwain Ezequiel JavierChief Commercial Officer
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027437 · ownership.xml · nonDerivative · entry 1 Brandwain Ezequiel Javier · CIK 0001908205 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2023, January 1, 2024 and January 1, 2025, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:15 UTC |
Zigdon Shoshana Yael10% owner
|
SaleCommon Stock | 10,000 | $1.06 | $10,600.00 |
DisclosureSEC source: 0001493152-21-028745 · ownership.xml · nonDerivative · entry 2 Zigdon Shoshana Yael · CIK 0001866707 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,305,000 Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:15 UTC |
Zigdon Shoshana Yael10% owner
|
SaleCommon Stock | 75,000 | $1.05 | $78,750.00 |
DisclosureSEC source: 0001493152-21-028745 · ownership.xml · nonDerivative · entry 1 Zigdon Shoshana Yael · CIK 0001866707 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,315,000 Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:15 UTC |
Zigdon Shoshana Yael10% owner
|
SaleCommon Stock | 20,000 | $1.15 | $23,000.00 |
DisclosureSEC source: 0001493152-21-027889 · ownership.xml · nonDerivative · entry 3 Zigdon Shoshana Yael · CIK 0001866707 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,390,000 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:15 UTC |
Zigdon Shoshana Yael10% owner
|
SaleCommon Stock | 40,000 | $1.14 | $45,600.00 |
DisclosureSEC source: 0001493152-21-027889 · ownership.xml · nonDerivative · entry 2 Zigdon Shoshana Yael · CIK 0001866707 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.